Androgen-independent expression of adrenomedullin and peptidylglycine α-amidating monooxygenase in human prostatic carcinoma
- 22 August 2003
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 38 (1) , 14-24
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Hormonal treatment for prostate cancerExpert Opinion on Investigational Drugs, 2001
- Androgen-independent growth is induced by neuropeptides in human prostate cancer cell linesThe Prostate, 1999
- Expression of Adrenomedullin and Proadrenomedullin N-terminal 20 Peptide in Human and Rat ProstateJournal of Histochemistry & Cytochemistry, 1999
- Autocrine/paracrine role of adrenomedullin in cultured endothelial and mesangial cellsKidney International, 1998
- Adrenomedullin Expression in Human Tumor Cell Lines ITS POTENTIAL ROLE AS AN AUTOCRINE GROWTH FACTORJournal of Biological Chemistry, 1996
- Regulation of prostatic growth and function by peptide growth factorsThe Prostate, 1996
- C-Terminal amidated peptides: Production by the in vitro enzymatic amidation of glycine-extended peptides and the importance of the amide to bioactivityEnzyme and Microbial Technology, 1994
- Cloning and Characterization of cDNA Encoding a Precursor for Human AdrenomedullinBiochemical and Biophysical Research Communications, 1993
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993
- Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implicationsCancer, 1992